-
1
-
-
84877090792
-
United Nations Office on Drugs and Crime Vienna
-
UNODC, United Nations New York 2010. Avalaible, Accessed 2012 Feb 14
-
UNODC, United Nations Office on Drugs and Crime Vienna. World Drug Report 2010. United Nations New York 2010. Avalaible: http://www.unodc.org/unodc/en/data-and-analysis/WDR-2010.html. Accessed 2012 Feb 14.
-
World Drug Report 2010
-
-
-
2
-
-
75149124452
-
Overview of amphetamine-type stimulant mortality data-UK 1997-2007
-
Schifano F, Corkery J, Naidoo V, Oyefeso A, Ghodse H, (2010) Overview of amphetamine-type stimulant mortality data-UK 1997-2007. Neuropsychobiology 61: 122-130.
-
(2010)
Neuropsychobiology
, vol.61
, pp. 122-130
-
-
Schifano, F.1
Corkery, J.2
Naidoo, V.3
Oyefeso, A.4
Ghodse, H.5
-
3
-
-
71949112153
-
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study
-
Martín-Santos R, Torrens M, Poudevida S, Langohr K, Cuyás E, et al. (2010) 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study. Addict Biol 15: 15-22.
-
(2010)
Addict Biol
, vol.15
, pp. 15-22
-
-
Martín-Santos, R.1
Torrens, M.2
Poudevida, S.3
Langohr, K.4
Cuyás, E.5
-
4
-
-
63449104991
-
The harmful health effects of recreational ecstasy: a systematic review of observational evidence
-
Rogers G, Elston J, Garside R, Roome C, Taylor R, et al. (2009) The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health Tecnology Assessment Vol 13: No 6.
-
(2009)
Health Tecnology Assessment
, vol.13
, Issue.6
-
-
Rogers, G.1
Elston, J.2
Garside, R.3
Roome, C.4
Taylor, R.5
-
5
-
-
51849104660
-
Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study
-
de Sola S, Tarancón T, Peña-Casanova J, Espadaler JM, Langohr K, et al. (2008) Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. Psychopharmacology (Berl) 200: 425-437.
-
(2008)
Psychopharmacology (Berl)
, vol.200
, pp. 425-437
-
-
de Sola, S.1
Tarancón, T.2
Peña-Casanova, J.3
Espadaler, J.M.4
Langohr, K.5
-
6
-
-
49349105923
-
Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study
-
de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, et al. (2008) Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. J Psychopharmacol 22: 498-510.
-
(2008)
J Psychopharmacol
, vol.22
, pp. 498-510
-
-
de Sola Llopis, S.1
Miguelez-Pan, M.2
Peña-Casanova, J.3
Poudevida, S.4
Farré, M.5
-
9
-
-
33846937530
-
Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
-
Allott K, Redman J, (2007) Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?. Neurosci Biobehav Rev 31: 327-347.
-
(2007)
Neurosci Biobehav Rev
, vol.31
, pp. 327-347
-
-
Allott, K.1
Redman, J.2
-
10
-
-
47249166411
-
Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults
-
Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, et al. (2008) Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit 30: 320-332.
-
(2008)
Ther Drug Monit
, vol.30
, pp. 320-332
-
-
Kolbrich, E.A.1
Goodwin, R.S.2
Gorelick, D.A.3
Hayes, R.J.4
Stein, E.A.5
-
11
-
-
81155134345
-
The influence of genetic and environmental factors among MDMA users in cognitive performance
-
Cuyàs E, Verdejo-García A, Fagundo AB, Khymenets O, Rodríguez J, et al. (2011) The influence of genetic and environmental factors among MDMA users in cognitive performance. PLoS One 6: e27206.
-
(2011)
PLoS One
, vol.6
-
-
Cuyàs, E.1
Verdejo-García, A.2
Fagundo, A.B.3
Khymenets, O.4
Rodríguez, J.5
-
12
-
-
24044524548
-
MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers
-
de la Torre R, Farré M, Mathúna BO, Roset PN, Pizarro N, et al. (2005) MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers. Eur J Clin Pharmacol 61: 551-554.
-
(2005)
Eur J Clin Pharmacol
, vol.61
, pp. 551-554
-
-
de la Torre, R.1
Farré, M.2
Mathúna, B.O.3
Roset, P.N.4
Pizarro, N.5
-
13
-
-
0042331424
-
Drug addiction
-
Camí J, Farré M, (2003) Drug addiction. N Engl J Med 349: 975-986.
-
(2003)
N Engl J Med
, vol.349
, pp. 975-986
-
-
Camí, J.1
Farré, M.2
-
14
-
-
0006463359
-
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
-
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531.
-
(1996)
Science
, vol.274
, pp. 1527-1531
-
-
Lesch, K.P.1
Bengel, D.2
Heils, A.3
Sabol, S.Z.4
Greenberg, B.D.5
-
15
-
-
50249104076
-
Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders
-
Harrison PJ, Tunbridge EM, (2008) Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 33: 3037-3045.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 3037-3045
-
-
Harrison, P.J.1
Tunbridge, E.M.2
-
16
-
-
70349386728
-
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part I
-
Zhou SF, (2009) Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part I. Clin Pharmacokinet. 48: 689-723.
-
(2009)
Clin Pharmacokinet
, vol.48
, pp. 689-723
-
-
Zhou, S.F.1
-
17
-
-
67649389513
-
Neurotoxic thioether adducts of MDMA identified in human urine after Ecstasy ingestion
-
Perfetti X, O'Mathúna B, Pizarro N, Cuyàs E, Khymenets O, et al. (2009) Neurotoxic thioether adducts of MDMA identified in human urine after Ecstasy ingestion. Drug Metabol Disp 37: 1448-1455.
-
(2009)
Drug Metabol Disp
, vol.37
, pp. 1448-1455
-
-
Perfetti, X.1
O'Mathúna, B.2
Pizarro, N.3
Cuyàs, E.4
Khymenets, O.5
-
18
-
-
33750368923
-
Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA
-
Yang J, Jamei M, Heydari A, Yeo KR, de la Torre R, et al. (2006) Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA. J Psychopharmacol 20: 842-849.
-
(2006)
J Psychopharmacol
, vol.20
, pp. 842-849
-
-
Yang, J.1
Jamei, M.2
Heydari, A.3
Yeo, K.R.4
de la Torre, R.5
-
19
-
-
0033967676
-
Non-linear pharmacokinetics of MDMA ("Ecstasy") in humans
-
de la Torre R, Farré M, Ortuño J, Mas M, Brenneisen R, et al. (2000) Non-linear pharmacokinetics of MDMA ("Ecstasy") in humans. Br J Clin Pharmacol 49: 104-109.
-
(2000)
Br J Clin Pharmacol
, vol.49
, pp. 104-109
-
-
de la Torre, R.1
Farré, M.2
Ortuño, J.3
Mas, M.4
Brenneisen, R.5
-
20
-
-
4143152622
-
Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition
-
de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, et al. (2004) Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit 26: 137-144.
-
(2004)
Ther Drug Monit
, vol.26
, pp. 137-144
-
-
de la Torre, R.1
Farré, M.2
Roset, P.N.3
Pizarro, N.4
Abanades, S.5
-
21
-
-
2542600694
-
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics
-
Farré M, de la Torre R, Mathúna BO, Roset PN, Peiró AM, et al. (2004) Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology (Berl) 173: 364-375.
-
(2004)
Psychopharmacology (Berl)
, vol.173
, pp. 364-375
-
-
Farré, M.1
de la Torre, R.2
Mathúna, B.O.3
Roset, P.N.4
Peiró, A.M.5
-
22
-
-
79953328535
-
Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans
-
Yubero-Lahoz S, Pardo R, Farré M, O'Mahony B, Torrens M, et al. (2011) Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans. Clin Pharmacokinet 50: 319-329.
-
(2011)
Clin Pharmacokinet
, vol.50
, pp. 319-329
-
-
Yubero-Lahoz, S.1
Pardo, R.2
Farré, M.3
O'Mahony, B.4
Torrens, M.5
-
23
-
-
65949093277
-
The consequences of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) induced CYP2D6 inhibition in humans
-
O'Mathúna B, Farré M, Rostami-Hodjegan A, Yang J, Cuyàs E, et al. (2008) The consequences of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) induced CYP2D6 inhibition in humans. J Clin Psychopharmacol 28: 523-529.
-
(2008)
J Clin Psychopharmacol
, vol.28
, pp. 523-529
-
-
O'Mathúna, B.1
Farré, M.2
Rostami-Hodjegan, A.3
Yang, J.4
Cuyàs, E.5
-
24
-
-
3042744925
-
Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV
-
Torrens M, Serrano D, Astals M, Pérez-Domínguez G, Martín-Santos R, (2004) Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am J Psychiatry 161: 1231-1237.
-
(2004)
Am J Psychiatry
, vol.161
, pp. 1231-1237
-
-
Torrens, M.1
Serrano, D.2
Astals, M.3
Pérez-Domínguez, G.4
Martín-Santos, R.5
-
25
-
-
0032968382
-
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans
-
Mas M, Farré M, de la Torre R, Roset PN, Ortuño J, et al. (1999) Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 290: 136-145.
-
(1999)
J Pharmacol Exp Ther
, vol.290
, pp. 136-145
-
-
Mas, M.1
Farré, M.2
de la Torre, R.3
Roset, P.N.4
Ortuño, J.5
-
26
-
-
18344382718
-
Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis
-
Pizarro N, Ortuño J, Farré M, Hernández-López C, Pujadas M, et al. (2002) Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. J Anal Toxicol 26: 157-165.
-
(2002)
J Anal Toxicol
, vol.26
, pp. 157-165
-
-
Pizarro, N.1
Ortuño, J.2
Farré, M.3
Hernández-López, C.4
Pujadas, M.5
-
27
-
-
77953436128
-
The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users
-
Fagundo AB, Cuyàs E, Verdejo-Garcia A, Khymenets O, Langohr K, et al. (2010) The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users. J Psychopharmacol 24: 1381-1393.
-
(2010)
J Psychopharmacol
, vol.24
, pp. 1381-1393
-
-
Fagundo, A.B.1
Cuyàs, E.2
Verdejo-Garcia, A.3
Khymenets, O.4
Langohr, K.5
-
28
-
-
77949632773
-
Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip
-
Cuyàs E, Olano-Martín E, Khymenets O, Hernández L, Jofre-Monseny L, et al. (2010) Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip. Pharmacogenomics 11: 257-266.
-
(2010)
Pharmacogenomics
, vol.11
, pp. 257-266
-
-
Cuyàs, E.1
Olano-Martín, E.2
Khymenets, O.3
Hernández, L.4
Jofre-Monseny, L.5
-
29
-
-
0033941158
-
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects
-
Cami J, Farré M, Mas M, Roset PN, Poudevida S, et al. (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects. J Clin Psychopharmacol 20: 455-466.
-
(2000)
J Clin Psychopharmacol
, vol.20
, pp. 455-466
-
-
Cami, J.1
Farré, M.2
Mas, M.3
Roset, P.N.4
Poudevida, S.5
-
30
-
-
36348943019
-
Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics
-
Farré M, Abanades S, Roset PN, Peiró AM, Torrens M, et al. (2007) Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics. J Pharmacol Exp Ther 323: 954-962.
-
(2007)
J Pharmacol Exp Ther
, vol.323
, pp. 954-962
-
-
Farré, M.1
Abanades, S.2
Roset, P.N.3
Peiró, A.M.4
Torrens, M.5
-
31
-
-
0036339071
-
Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans
-
Gaedigk A, Bradford LD, Marcucci KA, Leeder JS, (2002) Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans. Clin Pharmacol Ther 72: 76-89.
-
(2002)
Clin Pharmacol Ther
, vol.72
, pp. 76-89
-
-
Gaedigk, A.1
Bradford, L.D.2
Marcucci, K.A.3
Leeder, J.S.4
-
32
-
-
0028264457
-
Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans
-
McLeod HL, Fang L, Luo X, Scott EP, Evans WE, (1994) Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans. J Pharmacol Exp Ther 270: 26-29.
-
(1994)
J Pharmacol Exp Ther
, vol.270
, pp. 26-29
-
-
McLeod, H.L.1
Fang, L.2
Luo, X.3
Scott, E.P.4
Evans, W.E.5
-
33
-
-
0038690573
-
Serotonin-related gene polymorphisms and central nervous system serotonin function
-
Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, et al. (2003) Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 28: 533-541.
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 533-541
-
-
Williams, R.B.1
Marchuk, D.A.2
Gadde, K.M.3
Barefoot, J.C.4
Grichnik, K.5
-
34
-
-
34250686532
-
The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology
-
Schwartz JB, (2007) The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology. Clin Pharmacol Ther 1: 87-96.
-
(2007)
Clin Pharmacol Ther
, vol.1
, pp. 87-96
-
-
Schwartz, J.B.1
-
35
-
-
58149083155
-
Serotonergic Neurotoxic Thioether Metabolites of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): Synthesis, Isolation, and Characterization of Diastereoisomers
-
Pizarro N, de la Torre R, Joglar J, Okumura N, Perfetti X, et al. (2008) Serotonergic Neurotoxic Thioether Metabolites of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): Synthesis, Isolation, and Characterization of Diastereoisomers. Chem Res Toxicol 21: 2272-2279.
-
(2008)
Chem Res Toxicol
, vol.21
, pp. 2272-2279
-
-
Pizarro, N.1
de la Torre, R.2
Joglar, J.3
Okumura, N.4
Perfetti, X.5
-
36
-
-
0025119634
-
Human liver catechol-O-methyltransferase pharmacogenetics
-
Boudíková B, Szumlanski C, Maidak B, Weinshilboum R, (1990) Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48: 381-389.
-
(1990)
Clin Pharmacol Ther
, vol.48
, pp. 381-389
-
-
Boudíková, B.1
Szumlanski, C.2
Maidak, B.3
Weinshilboum, R.4
-
37
-
-
84857872328
-
Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT
-
Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, et al. (2012) Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. J Psychopharmacol 26: 408-418.
-
(2012)
J Psychopharmacol
, vol.26
, pp. 408-418
-
-
Aitchison, K.J.1
Tsapakis, E.M.2
Huezo-Diaz, P.3
Kerwin, R.W.4
Forsling, M.L.5
-
38
-
-
84857890764
-
Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption
-
Wolff K, Tsapakis EM, Pariante CM, Kerwin RW, Forsling ML, et al. (2012) Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption. J Psychopharmacol 26: 419-428.
-
(2012)
J Psychopharmacol
, vol.26
, pp. 419-428
-
-
Wolff, K.1
Tsapakis, E.M.2
Pariante, C.M.3
Kerwin, R.W.4
Forsling, M.L.5
-
39
-
-
79960573947
-
The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans
-
Hysek CM, Simmler LD, Ineichen M, Grouzmann E, Hoener MC, et al. (2011) The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. Clin Pharmacol Ther 90: 246-255.
-
(2011)
Clin Pharmacol Ther
, vol.90
, pp. 246-255
-
-
Hysek, C.M.1
Simmler, L.D.2
Ineichen, M.3
Grouzmann, E.4
Hoener, M.C.5
-
40
-
-
0035674880
-
Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies
-
Liechti ME, Vollenweider FX, (2001) Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol 16: 589-598.
-
(2001)
Hum Psychopharmacol
, vol.16
, pp. 589-598
-
-
Liechti, M.E.1
Vollenweider, F.X.2
-
41
-
-
34748813696
-
Evolving knowledge of sex differences in brain structure, function, and chemistry
-
Cosgrove KP, Mazure CM, Staley JK, (2007) Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 62: 847-855.
-
(2007)
Biol Psychiatry
, vol.62
, pp. 847-855
-
-
Cosgrove, K.P.1
Mazure, C.M.2
Staley, J.K.3
-
42
-
-
0036159513
-
Diverse actions of ovarian steroids in the serotonin neural system
-
Bethea CL, Lu NZ, Gundlah C, Streicher JM, (2002) Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23: 41-100.
-
(2002)
Front Neuroendocrinol
, vol.23
, pp. 41-100
-
-
Bethea, C.L.1
Lu, N.Z.2
Gundlah, C.3
Streicher, J.M.4
-
43
-
-
33845746879
-
High systolic blood pressure is associated with Val/Val genotype in the catechol-o-methyltransferase gene The Nord-Trøndelag Health Study (HUNT)
-
Hagen K, Pettersen E, Stovner LJ, Skorpen F, Holmen J, et al. (2007) High systolic blood pressure is associated with Val/Val genotype in the catechol-o-methyltransferase gene The Nord-Trøndelag Health Study (HUNT). Am J Hypertens 20: 21-26.
-
(2007)
Am J Hypertens
, vol.20
, pp. 21-26
-
-
Hagen, K.1
Pettersen, E.2
Stovner, L.J.3
Skorpen, F.4
Holmen, J.5
-
44
-
-
12444344813
-
Preliminary evidence of the cardiovascular effects of polysubstance misuse in nightclubs
-
Cole JC, Sumnall HR, Smith GW, Rostami-Hodjegan A, (2005) Preliminary evidence of the cardiovascular effects of polysubstance misuse in nightclubs. J Psychopharmacol. 19: 67-70.
-
(2005)
J Psychopharmacol
, vol.19
, pp. 67-70
-
-
Cole, J.C.1
Sumnall, H.R.2
Smith, G.W.3
Rostami-Hodjegan, A.4
-
45
-
-
80052329709
-
MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study
-
Parrott AC, Gibbs A, Scholey AB, King R, Owens K, et al. (2011) MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. Psychopharmacology (Berl) 215: 527-536.
-
(2011)
Psychopharmacology (Berl)
, vol.215
, pp. 527-536
-
-
Parrott, A.C.1
Gibbs, A.2
Scholey, A.B.3
King, R.4
Owens, K.5
-
46
-
-
33847756428
-
Effectiveness of low-intensity endurance training
-
Meyer T, Auracher M, Heeg K, Urhausen A, Kindermann W, (2007) Effectiveness of low-intensity endurance training. Int J Sports Med. 28: 33-39.
-
(2007)
Int J Sports Med
, vol.28
, pp. 33-39
-
-
Meyer, T.1
Auracher, M.2
Heeg, K.3
Urhausen, A.4
Kindermann, W.5
-
47
-
-
67650067597
-
Time course of changes in endurance capacity: a 1-yr training study
-
Scharhag-Rosenberger F, Meyer T, Walitzek S, Kindermann W, (2009) Time course of changes in endurance capacity: a 1-yr training study. Med Sci Sports Exerc. 41: 1130-1137.
-
(2009)
Med Sci Sports Exerc
, vol.41
, pp. 1130-1137
-
-
Scharhag-Rosenberger, F.1
Meyer, T.2
Walitzek, S.3
Kindermann, W.4
-
48
-
-
0033679118
-
Pharmacology of MDMA in humans
-
de la Torre R, Farré M, Roset PN, Lopez CH, Mas M, et al. (2000) Pharmacology of MDMA in humans. Ann NY Acad Sci 914: 225-237.
-
(2000)
Ann NY Acad Sci
, vol.914
, pp. 225-237
-
-
de la Torre, R.1
Farré, M.2
Roset, P.N.3
Lopez, C.H.4
Mas, M.5
-
49
-
-
58149474177
-
Perspective: sex matters: gonadal steroids and the brain
-
Young EA, Becker JB, (2009) Perspective: sex matters: gonadal steroids and the brain. Neuropsychopharmacology 34: 537-538.
-
(2009)
Neuropsychopharmacology
, vol.34
, pp. 537-538
-
-
Young, E.A.1
Becker, J.B.2
-
50
-
-
33750084178
-
Cortical trapping of alpha-[(11)C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males
-
Sakai Y, Nishikawa M, Leyton M, Benkelfat C, Young SN, et al. (2006) Cortical trapping of alpha-[(11)C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males. Neuroimage 33: 815-824.
-
(2006)
Neuroimage
, vol.33
, pp. 815-824
-
-
Sakai, Y.1
Nishikawa, M.2
Leyton, M.3
Benkelfat, C.4
Young, S.N.5
-
51
-
-
0037947438
-
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine
-
Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, et al. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186-6191.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 6186-6191
-
-
Mattay, V.S.1
Goldberg, T.E.2
Fera, F.3
Hariri, A.R.4
Tessitore, A.5
-
52
-
-
36049008131
-
The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans
-
Evans SM, (2007) The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans. Exp Clin Psychopharmacol 15: 418-426.
-
(2007)
Exp Clin Psychopharmacol
, vol.15
, pp. 418-426
-
-
Evans, S.M.1
-
53
-
-
80053302164
-
Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones
-
Anker JJ, Carroll ME, (2011) Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci 8: 73-96.
-
(2011)
Curr Top Behav Neurosci
, vol.8
, pp. 73-96
-
-
Anker, J.J.1
Carroll, M.E.2
|